JERSEY CITY, N.J., Aug. 23 /PRNewswire/ -- Dow Jones VentureWire announced today that its second annual ‘Health Care Innovations: Finding and Funding the Cures of Tomorrow’ conference ( http://healthcare.dowjones.com ), to be held on Tuesday and Wednesday, Sept. 12-13, 2006, at the Sofitel San Francisco Bay hotel in Redwood City, Calif., will include a ‘Keynote Interview’ -- ‘Pharma Perspectives’ -- whose participants will include: Dr. Robert Bagdorf, Executive Director, Licensing & Development, Pfizer; and, Robert Gould, Vice President, Licensing and External Research, Merck.
“Over the past six months, Merck and Pfizer have spent over $1 billion to acquire biopharmaceutical companies funded by venture capitalists. And both companies say they’re shopping for more. Attendees at our Health Care Innovations conference will hear directly from two pharmaceutical company executives who are in the market looking for new acquisition targets,” said Allan Cunningham, director of sales and marketing for Dow Jones Financial Information Services.
About VentureWire
VentureWire produces the leading daily newsletters and industry events for the venture capital market ( http://www.venturewire.com or www.venturecapital.dowjones.com ). VentureWire is a unit of Dow Jones Financial Information Services.
About Dow Jones Financial Information Services
Through its Financial Information Services group, Dow Jones produces focused, sector-specific online databases, newsletters and industry events for the private equity, venture capital and diversified markets. Newsletters published include Private Equity Analyst, VentureWire Professional and Daily Bankruptcy Review. In addition, Dow Jones & Company ( http://www.dowjones.com/ ) publishes the global Wall Street Journal with its international and online editions; Barron’s; the Far Eastern Economic Review; Dow Jones Newswires and Indexes; MarketWatch; and Ottaway newspapers. Dow Jones co-owns Factiva with Reuters and SmartMoney with Hearst. Dow Jones also provides news content to CNBC and U.S. radio stations.
Source: Dow Jones VentureWire
